Krause W, Effendy I
Z Hautkr. 1985 Jul 15;60(14):1147-55.
Inhibition of the testosterone synthesis caused by ketoconazole was studied in healthy young men. They received the drug for seven days at a dose of 200 mg daily. Neither the blood level of total plasma testosterone nor that of the free fraction showed any alteration during treatment. 24 hours after treatment, however, the response of plasma testosterone to hCG was diminished. These findings indicate a delayed effect of ketoconazole on the synthesis of testosterone, although its blood levels are decreased to nearly zero. The effects of ketoconazole are due to its binding to enzymatic proteins. Thus the link to other proteins binding androgens might be possible. Our experiments demonstrated that ketoconazole may inhibit the binding of testosterone to antibodies in a RIA system as well that to SHBG.
在健康年轻男性中研究了酮康唑引起的睾酮合成抑制作用。他们每天服用200毫克该药物,持续7天。治疗期间,血浆总睾酮水平和游离部分水平均未显示任何变化。然而,治疗后24小时,血浆睾酮对人绒毛膜促性腺激素(hCG)的反应减弱。这些发现表明酮康唑对睾酮合成有延迟作用,尽管其血液水平降至几乎为零。酮康唑的作用是由于其与酶蛋白结合。因此,与其他结合雄激素的蛋白质建立联系是可能的。我们的实验表明,酮康唑在放射免疫分析(RIA)系统中可能抑制睾酮与抗体的结合,以及与性激素结合球蛋白(SHBG)的结合。